Overview
Cognito Therapeutics develops non-invasive neuromodulation devices designed to modulate brain activity and support brain health through white matter preservation and brain plasticity enhancement. The company focuses on medical device solutions for neurodegenerative diseases, including Alzheimer's disease, with a mission to support brain function and cognitive health.
More in Neurotechnology
Latest industry news
Noninvasive Brain Interface Uses AI Suggestions to Triple Communication Speed
2026-11-21 · Research
Zhongke Borui Closes $15M Round to Scale Brain-Computer Interface Hardware in China
2026-11-20 · Funding
ALS Community Gains a Formal Voice in Brain-Computer Interface Development
2026-11-19 · Policy
Science Corporation Closes $400M Round to Push Brain-Computer Interface Technology Into the Clinic
2026-11-18 · Funding
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →